Convalescent Plasma News and Research

RSS
Study shows 19 out of 25 COVID-19 patients improved with convalescent plasma treatment

Study shows 19 out of 25 COVID-19 patients improved with convalescent plasma treatment

USP launches new program to accelerate the development of effective COVID-19 treatments

USP launches new program to accelerate the development of effective COVID-19 treatments

Passive immummization can offer instant, short-term fortification against infectious agents

Passive immummization can offer instant, short-term fortification against infectious agents

Varied performance of SARS-CoV-2 antibody tests in detecting protective immunity

Varied performance of SARS-CoV-2 antibody tests in detecting protective immunity

COVID survivors’ blood plasma is a sought-after new commodity

COVID survivors’ blood plasma is a sought-after new commodity

Researchers discover new type of antigen-presenting immune cell

Researchers discover new type of antigen-presenting immune cell

Children are immune prepared for SARS-CoV-2

Children are immune prepared for SARS-CoV-2

As coronavirus strikes, crucial data in electronic health records hard to harvest

As coronavirus strikes, crucial data in electronic health records hard to harvest

Temple University Hospital is offering COVID-19 clinical trials, investigational treatments options

Temple University Hospital is offering COVID-19 clinical trials, investigational treatments options

New clinical trial launched to study if convalescent plasma can treat COVID-19

New clinical trial launched to study if convalescent plasma can treat COVID-19

Scientists are developing synthetic COVID-19 antibody to treat sick patients

Scientists are developing synthetic COVID-19 antibody to treat sick patients

Convalescent plasma can be donated by COVID-19 survivors at Grifols’ donor centers

Convalescent plasma can be donated by COVID-19 survivors at Grifols’ donor centers

Immunity to coronavirus infection may help stem the pandemic

Immunity to coronavirus infection may help stem the pandemic

Penn Medicine launches convalescent plasma therapy trial for COVID-19 patients

Penn Medicine launches convalescent plasma therapy trial for COVID-19 patients

Gold-containing drug auranofin kills 95% of SARS-CoV-2 virus in 48 hours in lab conditions

Gold-containing drug auranofin kills 95% of SARS-CoV-2 virus in 48 hours in lab conditions

Octapharma USA supports new COVID-19 clinical trial

Octapharma USA supports new COVID-19 clinical trial

FDA grants Emergency Use Authorization to Ortho’s COVID-19 total antibody test

FDA grants Emergency Use Authorization to Ortho’s COVID-19 total antibody test

A desperate scramble as COVID-19 families vie for access to plasma therapy

A desperate scramble as COVID-19 families vie for access to plasma therapy

Johns Hopkins experts create clinical guidebook for convalescent plasma therapy

Johns Hopkins experts create clinical guidebook for convalescent plasma therapy

UChicago Medicine launches clinical trial to explore plasma transfusions for COVID-19 patients

UChicago Medicine launches clinical trial to explore plasma transfusions for COVID-19 patients